New finding in rare eye disease

Jul 14, 2008
New finding in rare eye disease

(PhysOrg.com) -- Researchers have made a finding which could pave the way for new treatments for sufferers of a rare eye disease which can lead to blindness.

In a paper published in the Journal of Pathology, scientists reveal they have discovered why mutations in a key gene can cause the cornea to go opaque and lead to sight loss.

Pax6 is the gene responsible for the development of the eye and mutations of it can cause the cornea to go cloudy.

Corneas - our windows on the world – are delicate, transparent tissues which are constantly exposed to potentially damaging environmental factors such as daylight, ultraviolet light and high levels of oxygen.

Normal corneas contain proteins that protect against the day to day stress of coping with these environmental stresses.

But around one in 40,000 people have Pax6 mutations which lead to them developing a condition called Aniridia, where the iris of the eye is missing.

As well as having no iris, most sufferers will develop some degree of corneal cloudyness which is called Aniridia-Related Keratopathy or ARK.

Now researchers have found that people with ARK have tiny holes in their corneas, which open up the corneas to extra levels of stress. They also discovered that they have less of the protective proteins, which results in their eyes being unable to cope with everyday conditions. Over time, this leads to the corneas going cloudy.

Dr Martin Collinson, a Senior Lecturer in Biomedical Sciences at the University of Aberdeen, led the research team. He said: "In the worst cases Aniridia-Related Keratopathy can be chronically painful and sight threatening. Current therapy is surgery, anti-inflammatory drugs, or nothing at all."

The researchers found that if they applied chemicals to diseased corneas, they were able to reduce the stress caused by oxygen. This in turn gave cells on the eye's surface more of a fighting chance of protecting the eye.

Dr Collinson added: "Our findings provide answers to a disease that has been very poorly understood and is rather difficult to treat.

"We hope that our studies could potentially lead to new treatments for people with ARK that could involve eye drops as opposed to surgery."

Source: University of Aberdeen

Explore further: The marmoset animal model recapitulates disease symptoms of MERS infection in humans

add to favorites email to friend print save as pdf

Related Stories

New type of solar concentrator desn't block the view

3 hours ago

(Phys.org) —A team of researchers at Michigan State University has developed a new type of solar concentrator that when placed over a window creates solar energy while allowing people to actually see through ...

Cities, states face off on municipal broadband

3 hours ago

Wilson, N.C., determined nearly a decade ago that high-speed Internet access would be essential to the community's social and economic health in the 21st century, just as electricity, water and sewers were in the previous ...

Recommended for you

American Ebola doc: 'I am thrilled to be alive'

2 hours ago

Calling it a "miraculous day," an American doctor infected with Ebola left his isolation unit and warmly hugged his doctors and nurses on Thursday, showing the world that he poses no public health threat ...

User comments : 0